Lalitha A V, Satish J K, Reddy Mounika, Ghosh Santu, George Jiny, Pujari Chandrakanth
Department of Pediatric Intensive Care, St Johns Medical College and Hospital, Bengaluru, Karnataka, India.
Department of Pediatrics, St Johns Medical College and Hospital, Bengaluru, Karnataka, India.
J Pediatr Intensive Care. 2021 Jun;10(2):110-117. doi: 10.1055/s-0040-1714705. Epub 2020 Jul 30.
Sequential organ failure assessment (SOFA) score is used as a predictor of outcome of sepsis in the pediatric intensive care unit. The aim of the study is to determine the application of SOFA scores as a predictor of outcome in children admitted to the pediatric intensive care unit with a diagnosis of sepsis. The design involved is prospective observational study. The study took place at the multidisciplinary pediatric intensive care unit (PICU), tertiary care hospital, South India. The patients included are children, aged 1 month to 18 years admitted with a diagnosis of sepsis (suspected/proven) to a single center PICU in India from November 2017 to November 2019. Data collected included the demographic, clinical, laboratory, and outcome-related variables. Severity of illness scores was calculated to include SOFA score day 1 (SF1) and day 3 (SF3) using a pediatric version (pediatric SOFA score or pSOFA) with age-adjusted cutoff variables for organ dysfunction, pediatric risk of mortality III (PRISM III; within 24 hours of admission), and pediatric logistic organ dysfunction-2 or PELOD-2 (days 1, 3, and 5). A total of 240 patients were admitted to the PICU with septic shock during the study period. The overall mortality rate was 42 of 240 patients (17.5%). The majority (59%) required mechanical ventilation, while only 19% required renal replacement therapy. The PRISM III, PELOD-2, and pSOFA scores correlated well with mortality. All three severity of illness scores were higher among nonsurvivors as compared with survivors ( < 0.001). pSOFA scores on both day 1 (area under the curve or AUC 0.84) and day 3 (AUC 0.87) demonstrated significantly higher discriminative power for in-hospital mortality as compared with PRISM III (AUC, 0.7), and PELOD-2 (day 1, [AUC, 0.73]), and PELOD-2 (day 3, [AUC, 0.81]). Utilizing a cutoff SOFA score of >8, the relative risk of prolonged duration of mechanical ventilation, requirement for vasoactive infusions (vasoactive infusion score), and PICU length of stay were all significantly increased ( < 0.05), on both days 1 and 3. On multiple logistic regression, adjusted odds ratio of mortality was elevated at 8.65 (95% CI: 3.48-21.52) on day 1 and 16.77 (95% confidence interval or CI: 4.7-59.89) on day 3 ( < 0.001) utilizing the same SOFA score cutoff of 8. A positive association was found between the delta SOFA ([Δ] SOFA) from day 1 to day 3 (SF1-SF3) and in-hospital mortality (chi-square for linear trend, < 0.001). Subjects with a ΔSOFA of ≥2 points had an exponential mortality rate to 50%. Similar association was-observed between ΔSOFA of ≥2 and-longer duration of inotropic support ( = 0.0006) with correlation co-efficient 0.2 (95% CI: 0.15-0.35; = 0.01). Among children admitted to the PICU with septic shock, SOFA scores on both days 1 and 3, have a greater discriminative power for predicting in-hospital mortality than either PRISM III score (within 24 hours of admission) or PELOD-2 score (days 1 and 3). An increase in ΔSOFA of >2 adds additional prognostic accuracy in determining not only mortality risk but also duration of inotropic support as well.
序贯器官衰竭评估(SOFA)评分被用作儿科重症监护病房中脓毒症预后的预测指标。本研究的目的是确定SOFA评分作为诊断为脓毒症的儿科重症监护病房患儿预后预测指标的应用情况。所采用的设计为前瞻性观察性研究。该研究在印度南部一家三级护理医院的多学科儿科重症监护病房(PICU)进行。纳入的患者为2017年11月至2019年11月期间因诊断为脓毒症(疑似/确诊)入住印度一家单一中心PICU的1个月至18岁儿童。收集的数据包括人口统计学、临床、实验室及与预后相关的变量。计算疾病严重程度评分,包括使用儿科版(儿科SOFA评分或pSOFA)计算第1天(SF1)和第3天(SF3)的SOFA评分,该版本具有针对器官功能障碍的年龄校正临界变量、儿科死亡风险III(PRISM III;入院后24小时内)以及儿科逻辑器官功能障碍-2或PELOD-2(第1天、第3天和第5天)。在研究期间,共有240例患者因感染性休克入住PICU。总死亡率为240例患者中的42例(17.5%)。大多数(59%)患者需要机械通气,而只有19%的患者需要肾脏替代治疗。PRISM III、PELOD-2和pSOFA评分与死亡率密切相关。与幸存者相比,非幸存者的所有三种疾病严重程度评分均更高(P<0.001)。第1天(曲线下面积或AUC为0.84)和第3天(AUC为0.87)的pSOFA评分与住院死亡率相比,与PRISM III(AUC为0.7)、PELOD-2(第1天,[AUC为0.73])和PELOD-2(第3天,[AUC为0.81])相比,具有显著更高的辨别力。使用>8的SOFA评分临界值,在第1天和第3天,机械通气时间延长、血管活性药物输注需求(血管活性药物输注评分)和PICU住院时间的相对风险均显著增加(P<0.05)。在多因素逻辑回归分析中,使用相同的SOFA评分临界值8时,第1天死亡率的调整优势比为8.65(95%CI:3.48 - 21.52),第3天为16.77(95%置信区间或CI:4.7 - 59.89)(P<0.001)。发现第1天至第3天的SOFA差值([Δ]SOFA)(SF1 - SF3)与住院死亡率之间存在正相关(线性趋势的卡方检验,P<0.001)。ΔSOFA≥2分的受试者死亡率呈指数级上升至50%。在ΔSOFA≥2与更长时间的血管活性药物支持之间也观察到类似的关联(P = 0.0006),相关系数为0.2(95%CI:0.15 - 0.35;P = 0.01)。在因感染性休克入住PICU的儿童中,第1天和第3天的SOFA评分在预测住院死亡率方面比PRISM III评分(入院后24小时内)或PELOD-2评分(第1天和第3天)具有更大的辨别力。ΔSOFA>2的增加不仅在确定死亡风险方面增加了额外的预后准确性,而且在确定血管活性药物支持的持续时间方面也增加了准确性。